Glaucoma is a group of eye conditions that progressively damage the optic nerve, the cable of nerve fibers that carries visual information from your eye to your brain. Around 95 million people worldwide currently live with some form of glaucoma, and that number is projected to reach nearly 112 million by 2040. What makes glaucoma particularly dangerous is that most forms produce no symptoms until significant, irreversible vision loss has already occurred.
How Glaucoma Damages Your Vision
Your eye constantly produces a clear fluid that nourishes its internal structures and maintains its shape. That fluid normally drains out through a small mesh-like channel near the front of the eye. When drainage slows or gets blocked, fluid builds up and pressure inside the eye rises. This pressure pushes against the back of the eye, where the optic nerve exits through a thin, sieve-like structure called the lamina cribrosa, the weakest point in the eye wall.
Under sustained pressure, this structure compresses and bows backward. That deformation squeezes the nerve fibers passing through it, disrupting the internal transport system that delivers essential nutrients from the brain back to the nerve cells in the retina. Without those nutrients, the nerve cells gradually die through a process called apoptosis, a kind of programmed self-destruction. The nerve cells affected are called retinal ganglion cells, and once they’re gone, they don’t regenerate. The vision they supported is permanently lost.
Adding to the problem, these nerve cells are energy-hungry. There’s evidence that the mitochondria (the energy-producing structures inside cells) malfunction under pressure-related stress, making it even harder for the cells to survive during periods of elevated eye pressure.
Types of Glaucoma
Open-Angle Glaucoma
This is the most common form, with a worldwide prevalence of about 3%. The drainage channel in the eye appears structurally open, but the microscopic mesh that filters the fluid becomes increasingly resistant to flow over time. Pressure rises slowly, and vision loss creeps in so gradually that most people don’t notice until the damage is advanced. It tends to cause deeper, more localized patches of nerve fiber damage, often worse in the upper half of the visual field. People of African descent are six to eight times more likely to develop this form than white people, and they tend to develop it about 10 years earlier than other groups.
Angle-Closure Glaucoma
In this form, the drainage channel is physically narrow or blocked. People who develop it often have eyes with a shallower front chamber, a thicker lens, or a shorter overall eye length, all of which crowd the drainage area. It can happen suddenly (an acute attack with severe eye pain, headache, nausea, and blurred vision) or develop gradually. Its global prevalence is lower, around 0.5%, but it’s most common among people of Asian descent. Angle-closure glaucoma tends to cause a more widespread, diffuse pattern of vision loss compared to the patchy damage of open-angle glaucoma.
Normal-Tension Glaucoma
This puzzling variant produces the same optic nerve damage and vision loss as other forms of glaucoma, but eye pressure measurements fall within the normal range. Diagnosis usually comes from noticing suspicious changes in the appearance of the optic nerve or from visual field testing that reveals defects. Small flame-shaped bleeds at the edge of the optic disc are more common in this form than in standard open-angle glaucoma and often signal that the disease is progressing. Even though pressure is technically “normal,” lowering it by about 30% has been shown to slow vision loss, making pressure reduction the primary treatment strategy here as well.
Symptoms and Why They’re Easy to Miss
Open-angle glaucoma, the most common type, produces no symptoms in its early stages. None. No pain, no redness, no blurred vision. What happens instead is a slow erosion of your peripheral (side) vision, starting with small patchy blind spots you’re unlikely to notice because your brain fills in the gaps. By the time central vision is affected, the disease is advanced. Normal-tension glaucoma follows a similar pattern, sometimes with gradually blurred vision before side vision narrows.
Acute angle-closure glaucoma is the exception. It announces itself with sudden, intense eye pain, headache, nausea, halos around lights, and rapid vision blurring. This is a medical emergency requiring immediate treatment to prevent permanent damage.
Who Is Most at Risk
Several factors increase your likelihood of developing glaucoma:
- Age: Risk rises significantly after 40, and everyone over 60 faces elevated risk regardless of ethnicity.
- African descent: Six to eight times higher risk than white populations, with onset typically a decade earlier. Glaucoma is the second leading cause of blindness in African Americans after cataracts.
- Asian descent: Higher risk specifically for angle-closure glaucoma.
- Hispanic descent: Also at elevated risk compared to the general population.
- Family history: Glaucoma runs in families. Having a first-degree relative with the condition meaningfully increases your risk.
- Diabetes and high blood pressure: Both are independent risk factors.
- Severe nearsightedness: Structural changes in highly myopic eyes increase vulnerability.
- Long-term steroid use: Prolonged use of corticosteroids, including those for asthma, can raise eye pressure.
How Glaucoma Is Diagnosed
Because glaucoma is usually silent, it’s caught through routine comprehensive eye exams rather than symptom-driven visits. Several tests work together to build the picture.
Tonometry measures the pressure inside your eye. The most common method involves a small probe gently touching the surface of your numbed eye. But pressure alone doesn’t tell the whole story, since normal-tension glaucoma exists and some people tolerate higher pressures without damage. Your doctor also examines the optic nerve directly, looking for a telltale enlargement of the central cup (the hollow area in the middle of the nerve head) relative to the overall disc. Stereo photographs of the nerve allow comparison over time.
Visual field testing maps your peripheral and central vision using a machine that flashes small lights at various positions while you focus on a central point. You press a button whenever you see a flash, and the resulting map reveals blind spots or areas of reduced sensitivity. This test is the primary way doctors track whether glaucoma is stable or worsening.
Optical coherence tomography (OCT) uses light waves to create detailed cross-sectional images of the retinal nerve fiber layer, detecting thinning that often precedes noticeable vision loss on field testing. Gonioscopy, where a special lens is placed on the eye, lets the doctor directly view the drainage angle to determine whether you have an open-angle or angle-closure form. Corneal thickness measurement (pachymetry) matters because thinner corneas can cause pressure readings to appear falsely low, potentially masking the disease.
Treatment: Eye Drops and Beyond
All current glaucoma treatment centers on one goal: lowering eye pressure. It’s the only modifiable factor proven to slow or halt nerve damage, even in normal-tension cases. Treatment can’t restore lost vision, but it can preserve what remains.
Most people start with prescription eye drops. The main categories work in two ways. Some reduce the amount of fluid your eye produces: beta-blockers, carbonic anhydrase inhibitors, and alpha agonists all fall into this group. Others increase fluid drainage through alternative outflow pathways, primarily prostaglandin analogs, which are the most commonly prescribed first-line drops. Many people end up using a combination. The drops are typically used once or twice daily, and consistency matters because skipping doses lets pressure climb back up.
When drops aren’t enough or aren’t tolerated well, laser treatment is often the next step. Selective laser trabeculoplasty (SLT) targets the drainage mesh with brief pulses of light to improve fluid outflow. It’s a quick, low-risk office procedure effective for mild to moderate open-angle glaucoma. In a three-year follow-up study, SLT kept eye pressure at or below 21 mmHg in over 93% of patients (though most still needed some medication). Some doctors now offer SLT as a first-line treatment before drops.
Minimally invasive glaucoma surgery (MIGS) involves implanting tiny devices or creating micro-openings in the drainage system, often during cataract surgery. These procedures carry less risk than traditional surgery but produce moderate pressure reductions, making them best suited for mild to moderate disease. For advanced or rapidly progressing glaucoma, traditional filtering surgery (trabeculectomy) creates a new drainage pathway and can achieve lower pressures, though it carries higher risks of complications.
Recommended Screening Schedule
The American Academy of Ophthalmology recommends that all adults without risk factors get a baseline comprehensive eye exam at age 40. After that, the schedule tightens with age: every two to four years from ages 40 to 54, every one to three years from 55 to 64, and every one to two years after 65.
If you’re in a higher-risk group, the timeline accelerates. African Americans should begin comprehensive exams by age 35, or sooner if they have diabetes. People with a family history of glaucoma, diabetes, high blood pressure, or severe nearsightedness should discuss earlier and more frequent screening with their eye doctor. Because glaucoma damage is irreversible and symptoms arrive late, these exams are the single most effective way to catch the disease while there’s still vision to protect.